Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2193-6536
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study ; volume:11 ; number:3 ; day:2 ; month:7 ; year:2022 ; pages:1353-1374 ; date:9.2022
Neurology and Therapy ; 11, Heft 3 (2.7.2022), 1353-1374, 9.2022

Urheber
Bourdès, Valérie
Dogterom, Peter
Aleman, André
Parmantier, Pierre
Colas, Damien
Lemarchant, Sighild
Marie, Sébastien
Chou, Thomas
Abd-Elaziz, Khalid
Godfrin, Yann
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40120-022-00380-6
URN
urn:nbn:de:101:1-2022101517304642991236
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:33 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Bourdès, Valérie
  • Dogterom, Peter
  • Aleman, André
  • Parmantier, Pierre
  • Colas, Damien
  • Lemarchant, Sighild
  • Marie, Sébastien
  • Chou, Thomas
  • Abd-Elaziz, Khalid
  • Godfrin, Yann
  • SpringerLink (Online service)

Ähnliche Objekte (12)

First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat

First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study

First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults

First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults

Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist

Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist

Pharmacokinetics and Pharmacodynamics of Posaconazole

Pharmacokinetics and Pharmacodynamics of Posaconazole

Journal of pharmacokinetics and pharmacodynamics

Zeitschrift

Journal of pharmacokinetics and pharmacodynamics

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp

Pharmacokinetics and Pharmacodynamics of Tedizolid

Pharmacokinetics and Pharmacodynamics of Tedizolid

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Clinical Pharmacokinetics and Pharmacodynamics of Afatinib

Clinical Pharmacokinetics and Pharmacodynamics of Afatinib

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib

Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide

Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide

Verbundene Objekte